Interleukin 6 in asymptomatic patients with nonsevere aortic valve stenosis: a post-hoc study of the SEAS trial von Hadziselimovic, E, Greve, A M, Sajadieh, A, Olsen, M H, Nienaber, C, Ray, S G, Rosseboe, A B, Wachtell, K, Nielsen, O W

Volltext

Validation of the developed ASGARD risk score for safe monitoring of asymptomatic patients with non-severe aortic valve stenosis von Hadziselimovic, E, Greve, A M G, Sajadieh, A S, Olsen, M H O, Kesaniemi, Y A K, Nienaber, C A N, Ray, S G R, Rosseboe, A B R, Wachtell, K W, Dominguez, H D, Koeber, N V K, Carstensen, H G C, Nielsen, O W N

Volltext

ASGARD risk scores for long-term, individualized cardiovascular surveillance of low-risk patients with asymptomatic non-severe aortic valve stenosis: development and internal valid... von Hadziselimovic, E, Greve, A M G, Sajadieh, A S, Olsen, M H O, Kesaniemi, Y A K, Nienaber, C A N, Ray, S G R, Rosseboe, A B R, Wachtell, K W, Dominguez, H D, Koeber, N V K, Carstensen, H G C, Nielsen, O W N

Volltext

Impact of QRS Duration and Morphology on the Risk of Sudden Cardiac Death in Asymptomatic Patients With Aortic Stenosis: The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Stu... von GREVE, Anders M, GERDTS, Eva, BOMAN, Kurt, GOHLKE-BAERWOLF, Christa, ROSSEBØ, Anne B, DEVEREUX, Richard B, KØBER, Lars, RAY, Simon, WILLENHEIMER, Ronnie, WACHTELL, Kristian

Volltext